Corrigendum to “PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor” [Volume 14, Issue 9, September 2021, 101152]
| Autor: | Koga, Satoko a, b, Onishi, Hideya a, ⁎, Masuda, Shogo a, Fujimura, Akiko a, Ichimiya, Shu a, b, Nakayama, Kazunori a, b, Imaizumi, Akira a, Nishiyama, Kenichi b, c, Kojima, Masayuki b, c, Miyoshi, Kei b, Nakamura, Katsuya d, Umebayashi, Masayo e, Morisaki, Takashi e, Nakamurab, Masafumi b |
|---|---|
| Zdroj: | In Translational Oncology March 2022 17 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|